Jeffrey Friedland will be participating and chairing a panel at the inaugural Institutional Capital & Cannabis Investment Conference (IC³). IC³ will take place March 28-29, 2017 in San Jose at the Hayes Mansion.
The event is being sponsored by MedMen and IMN.
IC3 will be focused on the legal cannabis business as an alternative asset class to achieve portfolio diversification. This event has been created specifically with the needs of institutional and family office investors in mind.
The program will provide an in-depth look at the emerging cannabis industry and provide attendees with valuable information regarding evaluating investment returns in the legal cannabis industry.
Jeffrey Friedland will chair the panel, “Public Company Investments in the Cannabis Industry.” On his panel will be Matt Shalhoub, Managing Director of Green Acre Capital; Brett Roper, Founder and Chief Operating Officer of Medicine Man Technologies; Alan Brochstein, Founding Partner of New Cannabis Ventures; and Aaron Salz, Chief Executive Officer of Stoic Advisory Inc.
In addition to Jeffrey Friedland, other speakers and panelists will include, Lindy Snider of Lindi Skin, Alan Bankier, an early-stage investor and serial entrepreneur, Kevin McGovern of McGovern Capital, Igor Gimelshtein of MedReleaf, Tripp Keber of Dixie Brands, Teddy Scott of PharmaCann, Jim Flanigan of Granite Hall, Jonathan Kaiser of Western Avenue Capital, George Stone of Kalyx Development, Rob Kampia of the Marijuana Policy Project, and Aaron Smith of the National Cannabis Industry Association.
In attendance at the event will be a Who’s Who of investment firms including MedMen, Privateer, and Casa Verde. Also in attendance will be owners and operators of state-licensed marijuana businesses including MedReleaf and Dixie Brands.
The executive directors of both the National Cannabis Industry Association and Marijuana Policy Project will also be participating in the conference, as will family office and institutional investors who have invested in the cannabis industry.
In commenting on this participation at IC³, Jeffrey Friedland stated, “As California, the world’s sixth largest economy, gears up for full marijuana legalization I am delighted to be participating in this important West Coast conference, focused on the legal cannabis business as an alternative asset class to achieve portfolio diversification.”
In addition to the panel chaired by Jeffrey Friedland, other sessions will include:
Investment Opportunities: Private and Public Capital Investment in the Cannabis Sector: A look at Private Equity, Real Estate, Public Markets and Venture Capital
Conscious Capitalism: How Commercial Opportunities Help Drive Social Justice in the Cannabis space
Why Family Offices: The Unique Opportunity
How to Invest: The Outsized Risk Adjusted Return in Real Estate
The Owner/Operator Perspective on Capital Raising
Navigating the Regulatory Environment
How to Invest: Single Asset Deals vs. Pooled Deals
The Future of Cannabis
If you’re interested in attending as a guest of Jeffrey Friedland, please email Scott Brody at firstname.lastname@example.org for a complimentary pass. For conference specifics, including the full agenda, please visit www.imn.org/ic3
About the Sponsors
The Institutional Capital & Investment Conference is being sponsored by MedMen, a cannabis management services company and investment firm, and the global financial community event sponsor, IMN.
IC3 is being supported by the National Cannabis Industry Association, The California Industry Cannabis Association and the Marijuana Policy Project.
About Jeffrey Friedland
Jeffrey Friedland is an emerging market pioneer -- his firm, Friedland Global Capital, was one of the first American investment banks to establish a presence in China -- and is now on the front lines of the cannabis industry as an investor and business owner. He is an author, speaker and thought leader on emerging markets, the global economy, and the cannabis industry.
In his book, Marijuana, the World's Most Misunderstood Plant, Mr. Friedland dives into the world of marijuana, discussing what we know and what we still hope to discover. The book is available in print and Kindle editions at http://www.amazon.com/author/jeffreyfriedlandAmazon.
Mr. Friedland was an owner of two retail marijuana stores in Colorado which were located in the mountain resort towns of Breckenridge and Crested Butte, and a marijuana cultivation facility south of Steamboat Springs, which were featured in CNN's eight-part, reality series, High Profits.
He is also CEO of privately-held INTIVA Inc., which has operating businesses and investments in the cannabis industry in California, Colorado, Israel, and Canada.
He is a board member of Israel-based CannRX, a company focused on the development of cannabis-based pharmaceuticals in Israel.
Mr. Friedland is an early-stage investor in Israel-based, Israel Plant Sciences Ltd. (IPS), a company that is participating in Israel’s innovative agriculture and medicinal plant sectors and other agricultural related technologies. The company has four subsidiaries in Israel focused on cannabis.
Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director and chairman of the audit committee of a New York Stock Exchange listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.
Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.
Jeffrey Friedland is a regular contributor to CannaInvestor Magazine (http://cannainvestormag.com.)
(Jeffrey Friedland’s website: www.jeffreyfriedland.com)